Evolus Corp - EOLS Enterprise Value to EBITDA Ratio
The visualized EV/EBITDA market trend for Evolus, Inc. (EOLS), with a valuation of 0.00, is based on outsourcing drug development and logistics to third-party contractors. Growth is supported by the hiring of qualified sales agents and the retention of key quality specialists. Business resilience relies on the development of digital services for cosmetologists and the expansion of the client base within the aesthetic medicine segment.
EOLS (evolus.com): analytical breakdowns and indicator data
- market price and analyst price targets:
- issuer market value details:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
EOLS - Final Profit|Projected Future Earnings Evolus, Inc.|EOLS - Business Payback Period|Future Price to Earnings Evolus, Inc.|EOLS - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Evolus Corp|EOLS - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Evolus|EOLS - Net earnings per share for the last four quarters|Quarterly EPS earnings growth evolus.com|EOLS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Evolus, Inc.
Summary company analytics:Jeuveau (EOLS)
This indicator determines the business value relative to its operating profit, accounting for debt load and tax obligations. A decrease in value signals that the asset is undervalued, while an increase indicates an overheated valuation. By analyzing the current EV/EBITDA multiple, an investor assesses the efficiency of capital management. For Evolus, Inc. (EOLS), this metric confirms the resilience of the business model amid stable demand in aesthetic medicine.
Competitors of Evolus, Inc.
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HCA Healthcare HCA|THC: Enterprise Value to Operating Income Before Depreciation|FMS: Enterprise Value to EBITDA Ratio|solventum.com - Enterprise Value to Operating Income Before Depreciation Ratio|EHC: EV/EBITDA Multiple|Company Value to EBITDA Universal Health Services, Inc. (UHS)|Enterprise Value to EBITDA Ratio DVA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RDNT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Option Care Health (OPCH)|SGRY - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Premier PINC|National Vision Holdings, Inc. - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|PGNY: Enterprise Value to EBITDA Ratio|ARDT - EV/EBITDA Multiple|Select Medical (SEM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ASTH - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio MD|USPH: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple PNTG|Total Company Value to Operating Income Before Depreciation Ratio Organogenesis Corp|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nutex Health Inc. NUTX|AUNA: Enterprise Value to Operating Income Before Depreciation|SBC Medical Group - EV/EBITDA Multiple|CHS (CYH) - Enterprise Value to EBITDA Ratio|SKIN (beautyhealth.com) - Enterprise Value to EBITDA Ratio|MDWD - Total Company Value to Operating Income Before Depreciation Ratio|BTMD (biote Corp.) - EV/EBITDA Multiple|Company Value to EBITDA thejoint.com JYNT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DocGo (DCGO)|PIII - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Gain Therapeutics, Inc. GANX|euda.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BMGL - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio CollPlant Biotechnologies CLGN|CUPR (Cuprina Holdings) - Enterprise Value to EBITDA Ratio|CCM: Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization American Shared Hospital Services, Inc.|MRM: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ALBT|DHAI - Company Value to EBITDA|EV/EBITDA Multiple XAGE (Carmell Therapeutics)|EV/EBITDA Multiple NewGenIvf Group NIVF|ATIP: Enterprise Value to EBITDA Ratio|CareMax, Inc - Enterprise Value to Operating Income Before Depreciation Ratio|Kindly MD, Inc. (KDLY) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio modivcare.com|NVOS (Novo Integrated Sciences, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA SunLink Health Systems, Inc SSY|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IMAC Regeneration Centers (BACK)
